Literature DB >> 12361630

Surface modification of polycaprolactone with poly(methacrylic acid) and gelatin covalent immobilization for promoting its cytocompatibility.

Yabin Zhu1, Changyou Gao, Jiacong Shen.   

Abstract

Polycaprolactone (PCL) membrane was modified by grafting copolymerization of methacrylic acid (MAA) initiated under UV light. The covalent immobilization of gelatin on PCL-g-PMAA surface was consequently performed by using condensing agent, 1-ethyl-3-(3-dimethylamino propyl) carbodiimide hydrochloride. The occurrence of grafting copolymerization of PMAA and further immobilization of gelatin was confirmed by ATR-FTIR and X-ray photoelectron spectroscopy characterizations. The existence of carboxyl groups grafted on PCL surface was verified quantitatively by absorbance spectroscopy where rhodamine 6G was employed to react with carboxyl groups to generate an absorbance at 512 nm. The endothelial cell culture proved that the PCL membrane slightly modified with suitable amount of PMAA or gelatin had better cytocompatibility than control PCL or PCL membrane heavily modified with PMAA or gelatin. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361630     DOI: 10.1016/s0142-9612(02)00247-8

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  26 in total

1.  Effects of nanotopography on stem cell phenotypes.

Authors:  Rajeswari Ravichandran; Susan Liao; Clarisse Ch Ng; Casey K Chan; Michael Raghunath; Seeram Ramakrishna
Journal:  World J Stem Cells       Date:  2009-12-31       Impact factor: 5.326

2.  Fabrication of electrospun polycaprolactone coated withchitosan-silver nanoparticles membranes for wound dressing applications.

Authors:  Tra Thanh Nhi; Huynh Chan Khon; Nguyen Thi Thu Hoai; Bui Chi Bao; Tran Ngoc Quyen; Vo Van Toi; Nguyen Thi Hiep
Journal:  J Mater Sci Mater Med       Date:  2016-09-12       Impact factor: 3.896

3.  Double protein functionalized poly-ε-caprolactone surfaces: in depth ToF-SIMS and XPS characterization.

Authors:  T Desmet; C Poleunis; A Delcorte; P Dubruel
Journal:  J Mater Sci Mater Med       Date:  2011-12-28       Impact factor: 3.896

Review 4.  3D Printing of Scaffolds for Tissue Regeneration Applications.

Authors:  Anh-Vu Do; Behnoush Khorsand; Sean M Geary; Aliasger K Salem
Journal:  Adv Healthc Mater       Date:  2015-06-10       Impact factor: 9.933

5.  Immobilisation of catalase on the surface of biodegradable starch-based polymers as a way to change its surface characteristics.

Authors:  S A Costa; R L Reis
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

6.  A multilayered valve leaflet promotes cell-laden collagen type I production and aortic valve hemodynamics.

Authors:  Aline L Y Nachlas; Siyi Li; Benjamin W Streeter; Kenneth J De Jesus Morales; Fatiesa Sulejmani; David Immanuel Madukauwa-David; Donald Bejleri; Wei Sun; Ajit P Yoganathan; Michael E Davis
Journal:  Biomaterials       Date:  2020-02-12       Impact factor: 12.479

7.  Sulfobetaine as a zwitterionic mediator for 3D hydroxyapatite mineralization.

Authors:  Pingsheng Liu; Jie Song
Journal:  Biomaterials       Date:  2013-01-16       Impact factor: 12.479

8.  Silk fibroin modified porous poly(epsilon-caprolactone) scaffold for human fibroblast culture in vitro.

Authors:  Guang Chen; Ping Zhou; Na Mei; Xin Chen; Zhengzhong Shao; Luanfeng Pan; Chungen Wu
Journal:  J Mater Sci Mater Med       Date:  2004-06       Impact factor: 3.896

9.  Radiolabeled gelatin type B analogues can be used for non-invasive visualisation and quantification of protein coatings on 3D porous implants.

Authors:  Ken Kersemans; Tim Desmet; Christian Vanhove; Peter Dubruel; Filip De Vos
Journal:  J Mater Sci Mater Med       Date:  2012-05-09       Impact factor: 3.896

10.  Combinatorial coating of adhesive polypeptide and anti-CD34 antibody for improved endothelial cell adhesion and proliferation.

Authors:  Min Yin; Yuan Yuan; Changsheng Liu; Jing Wang
Journal:  J Mater Sci Mater Med       Date:  2009-02-27       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.